Kiltearn Partners LLP Has $8.04 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Kiltearn Partners LLP trimmed its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 15.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 897,100 shares of the pharmacy operator’s stock after selling 162,400 shares during the period. Walgreens Boots Alliance comprises about 1.1% of Kiltearn Partners LLP’s portfolio, making the stock its 27th largest position. Kiltearn Partners LLP owned about 0.10% of Walgreens Boots Alliance worth $8,038,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Altrius Capital Management Inc increased its position in shares of Walgreens Boots Alliance by 76.6% in the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after acquiring an additional 190,996 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in Walgreens Boots Alliance by 23.4% in the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock valued at $3,050,000 after buying an additional 64,586 shares during the period. Sasco Capital Inc. CT boosted its stake in shares of Walgreens Boots Alliance by 13.6% during the 3rd quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock worth $9,331,000 after acquiring an additional 124,950 shares during the period. Van ECK Associates Corp raised its stake in Walgreens Boots Alliance by 21.3% in the 3rd quarter. Van ECK Associates Corp now owns 322,984 shares of the pharmacy operator’s stock valued at $3,019,000 after acquiring an additional 56,725 shares during the period. Finally, Scientech Research LLC acquired a new stake in Walgreens Boots Alliance during the 2nd quarter valued at $1,215,000. 58.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Evercore ISI boosted their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Bank of America reduced their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research note on Wednesday, September 4th. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $8.73 on Wednesday. The firm’s 50-day moving average price is $9.13 and its 200-day moving average price is $11.39. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.67 earnings per share. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 11.45%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.